Advertisement
U.S. Markets open in 1 hr 20 mins

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
9.65+0.02 (+0.21%)
At close: 04:00PM EST
9.50 -0.15 (-1.55%)
Pre-Market: 08:07AM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
-333
9,993
0
0
0
Operating Expense
77,701
74,528
82,950
105,618
94,466
Operating Income
-78,034
-64,535
-82,950
-105,618
-94,466
Net Non Operating Interest Income Expense
1,959
1,372
685
555
559
Other Income Expense
-85,014
-56,600
-243
-521
-54
Pretax Income
-161,089
-119,763
-82,508
-105,584
-93,961
Net Income Common Stockholders
-161,089
-119,763
-82,508
-105,584
-93,961
Diluted NI Available to Com Stockholders
-161,089
-119,763
-82,508
-105,584
-93,961
Basic EPS
-1.25
-1.42
-2.18
-4.12
-4.28
Diluted EPS
-1.25
-1.42
-2.18
-4.12
-4.28
Basic Average Shares
69,098
84,244
37,825
25,598
21,966
Diluted Average Shares
69,098
84,244
37,825
25,598
21,966
Total Operating Income as Reported
-78,034
-64,535
-82,950
-105,618
-94,466
Total Expenses
77,701
74,528
82,950
105,618
94,466
Net Income from Continuing & Discontinued Operation
-161,089
-119,763
-82,508
-105,584
-93,961
Normalized Income
-76,191
-63,190
-82,442
-105,584
-93,961
Interest Income
1,959
1,372
685
-
-
Net Interest Income
1,959
1,372
685
555
559
EBIT
-78,034
-64,535
-82,950
-105,618
-94,466
EBITDA
-77,668
-64,181
-82,507
-105,203
-94,086
Reconciled Depreciation
366
354
443
415
380
Net Income from Continuing Operation Net Minority Interest
-161,089
-119,763
-82,508
-105,584
-93,961
Total Unusual Items Excluding Goodwill
-84,898
-56,573
-66
-
-
Total Unusual Items
-84,898
-56,573
-66
-
-
Normalized EBITDA
7,230
-7,608
-82,441
-105,203
-94,086
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0